LYC (ASX) Fin review

Originally posted by Pout ↑

Skip to navigation Skip to content Skip to footer Help using this website - Accessibility statement

Menu

Advertisement

Companies

Mining

Exploration raisings top $3b with rare earths in rare air

Brad ThompsonReporter
IMO if you want to truly help rare earth supply chain. Give funding to Lynas domestically and help advance the US operations instead of speaking a big game, but having radio silence.
Save

Share
ASX-listed exploration companies raised more than $3 billion in the December quarter with a flood of money directed to rare earths, in another sign of how anxious the US and its western allies are to shore up non-China supply.
The raising bounced back from just $1.82 billion in July-September when a tightening in capital markets was blamed on global economic uncertainty.
Aspiring gold producers attracted the most finance ($379.68 million) for the second consecutive quarter, says a study by advisory firm BDO covering companies purely in the exploration phase, not yet making revenue.
Rare earths zoomed into second spot with $369.76 million raised in the three months, followed by lithium ($343.5 million) and old king coal with $282.9 million.
In the rare earths space, Hastings Technology Metals received $191.4 million in finance and acquired a 19.9 per cent stake in Toronto Stock Exchange-listed Neo Performance Materials thanks to the backing of Andrew Forrest’s privately owned Wyloo Metals.

and Rinehart emerged with a 10% stake in Arafura rare earths after pumping $60 million into a $121 million capital raising

The backing from the two iron ore billionaires came with the Albanese government taking a keen interest in financing of rare earths projects.
Treasurer Jim Chalmers confirmed on Wednesday that he had blocked Chinese businessman Wu Tao increasing his stake in Northern Minerals from 10 per cent to 19.9 per cent based on advice from the Foreign Investment Review Board.
BDO’s global head of natural resources, Sherif Andrawes, said Russia’s war on Ukraine and the subsequent supply chain disruptions in gas and other commodities appeared to have brought into sharper focus the Western world’s reliance on China for rare earths essential in electric vehicles, wind turbines, electronics and in defence applications from night vision goggles to guided missiles.
“Rare earths are important in everything from defence systems to iPhones and there is a realisation that we can’t be dependent on China forever, so there’s a search for alternative suppliers,” he said.
Mr Andrawes said aspiring rare earths producers with assets in Africa were reporting intense interest from the US in addition to the activity in Australia

The BDO analysis shows investment and exploration spending in the December quarter reached some of the highest levels since it started tracking the money flows almost a decade ago.
Across all of 2022, lithium explorers attracted the most finance ($1.2 billion) headed by fund raisings by the likes of Sayona Mining, Leo Lithium, Global Lithium and Core Lithium.
Gold came in second place with $1.15 billion followed by rare earths with almost $700 million.
Total exploration dipped to $993 million in the December quarter, down from a record spend of $1.07 billion on the hunt for new mining and oil and gas assets in the previous three months.
Mr Andrawes said the December quarter marked the second-highest tally of funds raised in any three-month period since 2013.
“Our explorers have more than bounced back from a very temporary dip, with record-high raisings seen this quarter,” he said.“

Gold explorers raised the most funds for the second consecutive quarter as growing inflation, geopolitical uncertainty and market volatility continued to drive demand,” he said.
“Gold is a well-recognised place for investors to turn to in times of geopolitical or economic uncertainty, and we are certainly facing these times at the moment.
“With the depth of expertise that ASX-listed explorers have in the gold sector - both for local and overseas projects - we can expect gold to attract increased funding, at least in the short term.”
In the fallout from global gold giant Newmont’s pursuit of biggest ASX-listed producer Newcrest and other deals in the making, BDO expects a round of consolidation in the sector.
BDO also sees no end in sight to the money flooding into the search for lithium and other energy transition metals with graphite, cobalt, uranium and nickel all prominent in capital raisings in 2022.
“We see gold, lithium and rare earth metals as the commodities of the moment, and we expect this trend to continue into 2023 and beyond,” Mr Andrawes said.

Expand

.

Cheers Pout
I think the below from your article post speaks volumes:

"IMO if you want to truly help rare earth supply chain. Give funding to Lynas domestically and help advance the US operations instead of speaking a big game, but having radio silence."

.

No.	Vol.	Price($)
18	3351	$7.81

No.

Vol.

Price($)

3351

$7.81

Price($)	Vol.	No.
$7.82	1403	8

Price($)

Vol.

No.

$7.82

1403

No.	Vol.	Price($)
4	1042	7.790
20	13156	7.780
12	10956	7.770
11	16619	7.760
12	22659	7.750

No.

Vol.

Price($)

1042

7.790

13156

7.780

10956

7.770

16619

7.760

22659

7.750

Price($)	Vol.	No.
7.800	3144	14
7.810	6051	16
7.820	5865	18
7.830	17336	13
7.840	7434	7

Price($)

Vol.

No.

7.800

3144

7.810

6051

7.820

5865

7.830

17336

7.840

7434

(20min delay)
Last $7.81		Change -0.080(1.01%)		Mkt cap ! $7.374B

Open	High	Low	Value	Volume
$7.85	$7.87	$7.77	$1.344M	171.8K

Fin review, page-2

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Firebird achieves preliminary approvals for its Jinshi plant design

PainChek close to finding out if FDA approves its flagship app for use in dementia care

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Fin review, page-2

Top Stories

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Firebird achieves preliminary approvals for its Jinshi plant design

PainChek close to finding out if FDA approves its flagship app for use in dementia care

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News